Medical Research News

RSS

Researchers develop new model to study aggressive melanomas

Researchers have created a powerful new cellular model to study rare tumors that are resistant to immunotherapies.

29 Jun 2026

New sedative prescriptions increase fall risks for discharged older adults

Older adults discharged from hospital with a new prescription for a sedative, especially a benzodiazepine or antipsychotic, are at increased risk of falls and other negative consequences, according to new research published in CMAJ (Canadian Medical Association Journal) https://www.cmaj.ca/lookup/doi/10.1503/cmaj.251965.

29 Jun 2026

Young adults miss health benefits by neglecting primary care doctors

A new survey commissioned by The Ohio State University Wexner Medical Center finds young adults are missing out on the health benefits of having a primary care doctor.

29 Jun 2026

Lithium MRI scans offer personalized treatments for bipolar disorder

A revolutionary scanning technique has revealed that lithium MRI is a powerful tool for studying how the drug interacts with the brain and could offer more personalized treatment for bipolar disorder.

29 Jun 2026

Simple blood test could identify the most effective obesity drug

Fasting blood tests measuring GLP-1 and GIP levels may predict obesity treatment response to semaglutide and tirzepatide, enhancing personalized therapy.

29 Jun 2026

One in three adults in England now lives with obesity

Obesity trends show significant disparities among demographics, stressing the importance of targeted prevention to address widening health inequalities.

29 Jun 2026

Brighter daytime light is linked to a lower dementia risk

The study finds that greater exposure to daytime light may lower dementia risk, pointing to light's role in enhancing circadian rhythms and cognitive function.

29 Jun 2026

Great ape laughter reveals how human vocal control evolved

A comparative study of laughter across humans and other great apes found that its regular rhythmic structure may date back around 15 million years. The findings suggest human laughter evolved toward faster, more variable, and more context-sensitive timing, reflecting greater vocal flexibility.

28 Jun 2026

Weak handgrip may not independently predict prostate cancer risk

New research suggests that low handgrip strength alone is not a reliable predictor of increased prostate cancer risk among older men.

28 Jun 2026

Unusual CD34+ dysplastic giant platelets complicate myelodysplastic syndrome diagnosis

Myelodysplastic syndromes (MDS) are a group of hematopoietic disorders characterized by ineffective hematopoiesis, with manifestations of cytopenias in one, two, or three lineages.

28 Jun 2026

Women with Parkinson's may be more vulnerable to Alzheimer's pathology

Women with Parkinson's disease may be more vulnerable to Alzheimer's-related changes in the brain than men, according to new research presented at the European Academy of Neurology (EAN) Congress 2026.

28 Jun 2026

Multiple sclerosis affects social life and work beyond physical health

Multiple sclerosis (MS) can have a substantial impact on many aspects of life beyond physical health, with 51% of people reporting that the disease affects their social life and 48% reporting that it affects their work, according to new research presented at the European Academy of Neurology (EAN) Congress 2026.

28 Jun 2026

Melatonin dampens fetal membrane inflammation linked to preterm birth

Melatonin reduced infection-related inflammation in human fetal membranes in an ex vivo model. The study suggests that this effect works partly through melatonin receptors and by suppressing the TLR4/MyD88/NF-κB pathway.

28 Jun 2026

Scientists discover 70 existing drugs that block deadly hantavirus infections

Researchers screened over 5,000 compounds and successfully pinpointed 70 existing drugs, including unexpected beta-lactam antibiotics, that effectively suppress Puumala orthohantavirus infection in human cells. This milestone drug-repurposing study provides an immediate, fast-tracked pipeline for developing the first approved treatments against life-threatening hantavirus diseases.

28 Jun 2026